Nova Patents
AT400274T

Inhibitors of akt activity

Abstract

The present invention is aimed at 2 and the compound containing 3* diphenyl quinoxaline portion which check the activity of Akt which are serine / threonine protein kinase. Furthermore, the present invention is aimed at the method of treating cancer including prescribing for the patient the composite for chemotherapies containing the compound of the present invention, and the compound of the present invention.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

13 members in 8 offices

This recordMember, by publication datePriority claim

Priority claims1

Priority claims
DocumentOfficeKindDate
28278101United States of AmericaP

Members13

Family members, oldest first
DocumentOfficeKind
CA2442270A1CanadaA1
WO02083138A1World Intellectual Property Organization (WIPO)A1
EP1379251A1European Patent Office (EPO)A1
US2004143117A1United States of AmericaA1
JP2004525961AJapanA
EP1379251A4European Patent Office (EPO)A4
US7034026B2United States of AmericaB2
AU2002252614B2AustraliaB2
EP1379251B1European Patent Office (EPO)B1
AT400274TThis recordAustriaT
DE60227492D1GermanyD1
CA2442270CCanadaC
JP4361276B2JapanB2